Literature DB >> 7688837

Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.

H G Drexler1, C Sperling, W D Ludwig.   

Abstract

Terminal deoxynucleotidyl transferase (TdT) was initially considered as a marker of immature lymphoid cells, but many studies have since provided conclusive evidence for the existence of TdT+ cases of acute myeloid leukemia (AML). The reported incidence of TdT+ AML cases varies largely (from 0% to 55%, average of combined data of the literature 18%, children 19%, and adults 21%) suggesting interlaboratory differences in the types of AML examined, the sensitivity of the method used, and the percentage of positive blasts taken as cut-off value. Significantly higher frequencies of TdT+ AML were reported in studies employing immunocytochemical staining (alkaline phosphatase anti-alkaline phosphatase or immunoperoxidase) than in series using immunofluorescence microscopy or biochemical assays. Statistical analysis of various cut-off levels demonstrates an inverse correlation between cut-off point and incidence. The combined data show that TdT-positivity is more common in the immature cell types (M0, M1), with no correlation with age or sex. Except for contested suggestions of an association with t(6;9) and t(8;21), no clear relationship between karyotype and TdT status has been documented. Although an association between T-cell receptor or immunoglobulin gene rearrangements and expression of TdT in AML was postulated, subsequent studies could not demonstrate this correlation. There was no significant relationship with other immunophenotypic markers except for CD34 positivity suggesting that the TdT+ cells represent an immature population. The percentage of positive cells was usually lower in AML than in ALL; in most cases only a subpopulation of the AML cells was TdT+. Thus, TdT could be viewed as a marker of hematopoietic immaturity. In about one-half of the studies on adults, TdT expression was reported to indicate a poor prognosis; others did not find any prognostic difference between TdT+ and TdT- AML cases. No correlation between TdT-positivity and prognosis was found in childhood AML.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688837

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation.

Authors:  Keyur P Patel; Faisal A Khokhar; Tariq Muzzafar; M James You; Carlos E Bueso-Ramos; Farhad Ravandi; Sherrie Pierce; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2012-08-31       Impact factor: 7.842

Review 2.  Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy.

Authors:  Alejandro Gutierrez; Alex Kentsis
Journal:  Br J Haematol       Date:  2018-02-14       Impact factor: 6.998

3.  Dntt expression reveals developmental hierarchy and lineage specification of hematopoietic progenitors.

Authors:  Fabian Klein; Julien Roux; Grozdan Cvijetic; Patrick Fernandes Rodrigues; Lilly von Muenchow; Ruth Lubin; Pawel Pelczar; Simon Yona; Panagiotis Tsapogas; Roxane Tussiwand
Journal:  Nat Immunol       Date:  2022-03-30       Impact factor: 31.250

4.  Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.

Authors:  Fernando P G Silva; Inês Almeida; Bruno Morolli; Geeske Brouwer-Mandema; Hans Wessels; Rolf Vossen; Harry Vrieling; Erik W A Marijt; Peter J M Valk; Hanneke C Kluin-Nelemans; Wolfgang R Sperr; Wolf-Dieter Ludwig; Micheline Giphart-Gassler
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

5.  Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma: a potential diagnostic pitfall.

Authors:  Alexander Brobeil; Florian Wagenlehner; Stefan Gattenlöhner
Journal:  Virchows Arch       Date:  2018-02-18       Impact factor: 4.064

6.  Characterization of aberrant phenotypes in acute myeloblastic leukemia.

Authors:  A Macedo; A Orfão; M B Vidriales; M C López-Berges; B Valverde; M González; M D Caballero; F Ramos; M Martínez; J Fernández-Calvo
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

7.  Expansion of the preimmune antibody repertoire by junctional diversity in Bos taurus.

Authors:  Jenni Liljavirta; Mikael Niku; Tiina Pessa-Morikawa; Anna Ekman; Antti Iivanainen
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

8.  DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma.

Authors:  Yuan-Jie Liu; Shu-Hong Zeng; Wei-Hua Qian; Min-Xian Tao; Ying-Ying Zhu; Jie-Pin Li
Journal:  Pharmgenomics Pers Med       Date:  2022-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.